PARP/EZH2-IN-1
PARP/EZH2-IN-1 is a first-in-class dual PARP-1/EZH2 inhibitor with IC50 values of 6.87 nM and 36.51 nM, respectively. PARP/EZH2-IN-1 induces autophagy in cancer cells and shows potent antiproliferative activity in BRCA wild-type triple-negative breast cancer cells.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2687273-52-3
- Formel: C43H41FN8O5
- Molecular Weight:768.83
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Histone Methyltransferase Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
PARP-1 6.87 nM (IC50) |
EZH2 36.51 nM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MCF-10A | IC50 |
>50 μM
Compound: 5a
|
Antiproliferative activity against human MCF-10A cells assessed as cell viability after 72 hrs by MTT assay
Antiproliferative activity against human MCF-10A cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 34455779] |
| MCF7 | IC50 |
12.11 μM
Compound: 5a
|
Antiproliferative activity against human MCF7 cells assessed as cell viability after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 34455779] |
| MDA-MB-231 | IC50 |
2.63 μM
Compound: 5a
|
Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 34455779] |
| MDA-MB-468 | IC50 |
0.41 μM
Compound: 5a
|
Antiproliferative activity against human MDA-MB-468 cells assessed as cell viability after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-468 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 34455779] |
In Vitro
PARP/EZH2-IN-1 (Compound 5a) (72 h) exhibits potent antiproliferative activity against MDA-MB-231 cells (IC50 = 2.63 μM) and MDA-MB-468 cells (IC50 = 0.41 μM)[1].
PARP/EZH2-IN-1 (72 h) shows weaker activity against MCF-7 cells (IC50 = 12.11 μM) and negligible cytotoxicity against MCF-10A cells (IC50 > 50 μM), and binds EZH2 with a Kd of 14.56 nM[1].
PARP/EZH2-IN-1 (0.5-7.5 μM; 48 h) downregulates BRCA1, BRCA2, EZH2, and CARM1 protein levels in MDA-MB-231 and MDA-MB-468 cells[1].
PARP/EZH2-IN-1 (2.5-7.5 μM; 48 h) induces excessive autophagy rather than apoptosis in MDA-MB-231 and MDA-MB-468 cells, accompanied by concentration-dependent increases of Beclin-1 and LC3B-II and a decrease of p62[1].
PARP/EZH2-IN-1 (7.5 μM; 0-32 h) modulates autophagy-related proteins in a time-dependent manner, leading to autophagic cell death after 8 h in MDA-MB-231 cells[1].
Knockdown of PARP-1 or EZH2 partially rescues the antiproliferative effect of PARP/EZH2-IN-1 in MDA-MB-231 and MDA-MB-468 cells. Additionally, the compound has basically no effect on cell apoptosis and reactive oxygen species (ROS) levels in these cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MDA-MB-231, MDA-MB-468, MCF-7, MCF-10A cells
-
Concentration:various concentrations
-
Incubation Time:72 h
-
Result:Exhibited potent antiproliferative activity against MDA-MB-231 cells (IC50 = 2.63 μM) and MDA-MB-468 cells (IC50 = 0.41 μM), weaker activity against MCF-7 cells (IC50 = 12.11 μM), and negligible cytotoxicity against MCF-10A cells (IC50 > 50 μM).
-
Cell Line:MDA-MB-231 and MDA-MB-468 cells
-
Concentration:2.5 μM, 5.0 μM, 7.5 μM (MDA-MB-231); 0.5 μM, 1.0 μM, 2.0 μM (MDA-MB-468)
-
Incubation Time:48 h
-
Result:Significantly down-regulated BRCA1, BRCA2, EZH2, and CARM1 protein levels.
-
Cell Line:MDA-MB-231 and MDA-MB-468 cells
-
Concentration:2.5 μM, 5.0 μM, 7.5 μM (MDA-MB-231); 0.5 μM, 1.0 μM, 2.0 μM (MDA-MB-468)
-
Incubation Time:48 h
-
Result:Increased Beclin-1 and LC3B-II expression and decreased p62 levels in a concentration-dependent manner.
-
Cell Line:MDA-MB-231 cells
-
Concentration:5.0 μM
-
Incubation Time:12 h
-
Result:Induced abundant autophagic vacuoles, autophagosomes, and autophagic lysosomes.
-
Cell Line:MDA-MB-231 and MDA-MB-468 cells
-
Concentration:2.5 μM, 5.0 μM, 7.5 μM (MDA-MB-231); 0.5 μM, 1.0 μM, 2.0 μM (MDA-MB-468)
-
Incubation Time:48 h
-
Result:Increased autophagosome formation and autophagic activity in a concentration-dependent manner as shown by MDC-EB staining and LC3B immunofluorescence.
Chemical Information
-
CAS. Nr. 2687273-52-3
-
Molecular Weight 768.83
-
Formel C43H41FN8O5
-
SMILES
O=C(C1=C(C(NC(C)=O)=CC(C2=CC=C(N=C2)N3CCN(CC3)C(C4=CC(CC5=NNC(C6=C5C=CC=C6)=O)=CC=C4F)=O)=C1)C)NCC7=C(C=C(NC7=O)C)C
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)